Theraclone Sciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

Theraclone Sciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Theraclone Sciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
Theraclone Sciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
28 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

Theraclone Sciences, Inc. (Theraclone) is a biotechnology company that develops therapeutic antibodies for the treatment of cancer and infectious diseases. The company identifies antibodies produced naturally by human memory B cells in response to disease-causing agents or conditions. It offers development programs on infectious disease that include novel antibodies to fight pandemic and seasonal influenza. Theraclones I-STAR technology provides screen to identify functional antibodies produced naturally by human memory B cells to protect against disease-causing agents.

Theraclone Sciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type,

  
Source:
Document ID
GDPH137452D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
Theraclone Sciences, Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
Theraclone Sciences, Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
Theraclone Sciences, Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
Theraclone Sciences, Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
Theraclone Sciences, Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 201692
Theraclone Sciences, Inc., Pharmaceuticals &Healthcare, Deal Details1114
  Venture Financing111
    Theraclone Sciences Raises US$8 Million In Extended Series B Financing112
    Theraclone Sciences Raises US$6 Million In Venture Financing131
    Theraclone Sciences Secures Additional US$1 Million In Extended Series B Financing142
    Theraclone Sciences Secures An Additional US$1.5 Million In Series B Venture Financing162
  Partnerships181
    University of Texas MD Anderson Cancer Center and Theraclone Sciences Form Joint Venture181
    Theraclone Sciences Enters Into Joint Venture With VLST To Form V-Gene191
    Theraclone Sciences Enters Into Co-Development Agreement With Pfizer201
  Merger211
    Pharmathene Terminates Merger With Theraclone Sciences212
  Licensing Agreements231
    Theraclone Sciences Enters into Licensing Agreement with Gilead Sciences231
    Zenyaku Kogyo Enters Into License Agreement With Theraclone241
Theraclone Sciences, Inc. - Key Competitors251
Key Employees261
Locations And Subsidiaries271
  Head Office271
Appendix281
  Methodology281
  About GlobalData281
  Contact Us281
  Disclaimer281

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "Theraclone Sciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Theraclone-Sciences-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-3052>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). Theraclone Sciences, Inc. - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/Theraclone-Sciences-Inc-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-3052>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research